These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39406907)

  • 41. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
    Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
    Front Immunol; 2021; 12():799428. PubMed ID: 34992609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors.
    Park SM; Chen CJ; Verdon DJ; Ooi MPY; Brooks AES; Martin RCW; Mathy JA; Emanuel PO; Dunbar PR
    Front Immunol; 2024; 15():1412076. PubMed ID: 38903497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.
    Zins K; Abraham D
    Methods Mol Biol; 2020; 2115():289-325. PubMed ID: 32006408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.
    Xu T; Yu S; Zhang J; Wu S
    J Hematol Oncol; 2021 Oct; 14(1):181. PubMed ID: 34717710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities.
    Hadad S; Khalaji A; Sarmadian AJ; Sarmadian PJ; Janagard EM; Baradaran B
    Int Immunopharmacol; 2024 Jul; 136():112406. PubMed ID: 38850795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression.
    Wang Y; Zhang J; Shi H; Wang M; Yu D; Fu M; Qian Y; Zhang X; Ji R; Wang S; Gu J; Zhang X
    Adv Sci (Weinh); 2024 Jun; 11(24):e2309298. PubMed ID: 38639382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.
    Bui I; Bonavida B
    Crit Rev Oncog; 2024; 29(4):75-95. PubMed ID: 38989739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage-conditioned medium enhances tunneling nanotube formation in breast cancer cells via PKC, Src, NF-κB, and p38 MAPK signaling.
    Melwani PK; Balla MMS; Bhamani A; Nandha SR; Checker R; Pandey BN
    Cell Signal; 2024 Sep; 121():111274. PubMed ID: 38936787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrophage-based cancer immunotherapy: Challenges and opportunities.
    Bai H; Feng L; Schmid F
    Exp Cell Res; 2024 Sep; 442(1):114198. PubMed ID: 39103071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: A review.
    Chabeli MS; Wang X; Yinghao L; Chen C; Yang C; Shou Y; Wang S; Chen K
    Cancer Treat Res Commun; 2022; 32():100621. PubMed ID: 36007473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyporus umbellatus polysaccharide iron-based nanocomposite for synergistic M1 polarization of TAMs and combinational anti-breast cancer therapy.
    Liu T; Han T; Liu C; Ge C; Jiang X; Liu Y; Kong F; Su X; Shi J; Su W; Li X; Chen Y; Zhang H; Ma Q; Qu D
    Int J Biol Macromol; 2023 Nov; 251():126323. PubMed ID: 37586629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammary hydroxylated oestrogen activates the NLRP3 inflammasome in tumor-associated macrophages to promote breast cancer progression and metastasis.
    Zhao H; Xu J; Zhong Y; He S; Hao Z; Zhang B; Liu Z; Zhou X
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113034. PubMed ID: 39226826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
    Tao H; Zhong X; Zeng A; Song L
    Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic reciprocal interactions between activated T cells and tumor associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models.
    Heninger E; Breneman MT; Recchia EE; Kerr SC; Dogru RE; Sharifi MN; LeBeau AM; Kosoff D
    Sci Rep; 2024 Oct; 14(1):24230. PubMed ID: 39414902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression.
    Li Y; Ganesan K; Chen J
    Curr Med Chem; 2022; 29(33):5420-5440. PubMed ID: 35619312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).
    Yu M; Yu H; Wang H; Xu X; Sun Z; Chen W; Yu M; Liu C; Jiang M; Zhang X
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
    Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
    Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination.
    Franzolin G; Brundu S; Cojocaru CF; Curatolo A; Ponzo M; Mastrantonio R; Mihara E; Kumanogoh A; Suga H; Takagi J; Tamagnone L; Giraudo E
    Cancer Immunol Res; 2024 Sep; 12(9):1286-1301. PubMed ID: 38874583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.